Global /China /Healthcare /Drug Manufacturers - General /002688
chevron_leftBack
Jinhe Biotechnology CO., LTD. logo

Jinhe Biotechnology CO., LTD.

002688
SHE: 002688 Delayed
6.02CNY 0%
0.8865 USD
As of 26 June 2026, Jinhe Biotechnology CO., LTD. has a market cap of $664.83M USD, ranking #13203 globally and #4003 in China. It ranks #1196 in the Healthcare sector, and #443 in the Drug Manufacturers - General industry.
Global Rank
13203
Country Rank
4003
Sector Rank
1196
Industry Rank
443
Key Stats
Market Cap
$664.83MUSD
4.51B CNY
Enterprise Value
$946.86MUSD
6.43B CNY
Revenue (TTM)
$423.8MUSD
2.88B CNY
EBITDA (TTM)
$83.62MUSD
567.89M CNY
Net Income (TTM)
$4.06MUSD
27.56M CNY
EBITDA Margin
20%
Profit Margin
1%
PE Ratio
170.5
Forward PE
20.1
PS Ratio
1.6
PB Ratio
1.8
EV/EBITDA
11.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Changxian Xie open_in_new
Employees
2,476
Founded
1990
Website
jinhe.com.cn open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 4.9% 2% -10% -11% -3.7%

News

Loading...

Markets

Exchange Ticker Price
Shenzhen Stock Exchange
MIC: XSHE
PRIMARY
002688
金河生物科技股份有限公司 Class A
ISIN: CNE100001HK7
Shares Out.:
755.683M1 Shares Float: 460.714M2
TV:
SA:
YF:
GF:
BA:
MS:
6.02 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Jinhe Biotechnology CO., LTD.

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China and internationally. It offers chlortetracycline premixes; veterinary drug and powder series; disinfectants; and sprinklers. It also engages in the production and sales of feed and raw materials. The company was founded in 1990 and is headquartered in Hohhot, China.

Similar Companies

Industry: Drug Manufacturers - General (China)
Name
Market Cap diff.
PE
$53.73B
364.89B CNY
8K%
44.9
603259
$49.53B
336.36B CNY
7K%
17.2
$28.5B
223.48B HKD
4K%
35.7
$18.79B
147.32B HKD
3K%
162.3
$16.48B
111.89B CNY
2K%
-
9926
$16.0B
125.46B HKD
2K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
114K%
38.1
JNJ
$547.28B
82K%
26.4
ABBV
$360.63B
54K%
97.4
$316.45B
256.25B CHF
47K%
19.9
AZN
$284.53B
215.59B GBP
43K%
27.6
MRK
$274.03B
41K%
15.1
chevron_leftBack